EvK Clinical Trial

​​EvK Clinical Trial Community Meeting Information​

Open community meetings were held April 4, 6 and 11, 2016 (Slides)

Community Advisory Panel (CAP) meetings were held on September 10, 2015 and November 3, 2016 (Slides)
Community Advisory Panel Update Meeting October 5, 2017 (Slides)

Additional community meetings will be scheduled if requested


EvK Clinical Trial Approval Letters

IRB Approval Letter - 2015-2016

IRB Continuing Review Approval Letter - 2016-2017

IRB Continuing Review Approval Letter - 2017-2018

​​

EvK Clinical Trial registration on ClinicalTrials.gov

The EvK Clinical Trial (NCT02643381)


Etomidate and ketamine information

Etomidate - National Library of Medicine Drug Information Portal 

Ketamine - National Library of Medicine Drug Information Portal


Information about FDA 21 CFR 50.24 - Exception From Informed Consent (EFIC) Research

FDA 21 CFR 50.24 detailed regulations - 1996